| Literature DB >> 33148721 |
Maria Yvonne Charumbira1, Karina Berner2, Quinette Abegail Louw2.
Abstract
OBJECTIVES: Recent research has indicated seemingly increased propensity for falls and accelerated bone demineralisation in people living with HIV (PLWH). We aim to map out the extent and nature of existing research relating to falls in PLWH and describe the relationship between bone demineralisation and falls in PLWH.Entities:
Keywords: HIV & AIDS; bone diseases; epidemiology; infectious disease/HIV
Year: 2020 PMID: 33148721 PMCID: PMC7674634 DOI: 10.1136/bmjopen-2019-034872
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Summary of study characteristics
| Study | Country | Study design | Aim | Eligibility criteria | Recommendations from the studies:a assessment;b intervention;c future research |
| Berner | Various | Systematic review | To synthesise the evidence of objective impairments of gait and balance associated with HIV-1 infection, and to emphasise those which could contribute to increased fall risk | Definition, prevalence, risk factors, assessment. | Ascertain 5STS (determined as most valid clinical test to screen for gait deviation impairments in a clinical setting) as predictive of falls in PLWH. |
| Explore knowledge among South African physiotherapists and first contact primary healthcare workers that fall risk may be increased in PLWH. | |||||
| Erlandson | USA | Longitudinal prospective cohort study | To determine incidence of and risk factors for falls in PLWH | Definition, prevalence, risk factors, assessment, intervention. | Falls risk should be routinely assessed as part of care of PLWH. |
| Validate fall prevention interventions that effectively reduce falls in older adults of general population for effectiveness in PLWH. | |||||
| Erlandson | USA | Longitudinal prospective cohort study | To (1) compare fall rates in PLWH or adults at risk for HIV, (2) determine if HIV infection is an independent fall risk, and (3) determine other fall risk factors potentially unique to HIV. | Definition, prevalence, risk factors, assessment, intervention. | During subjective assessments assess for complaints of lightheadedness, dizziness, feeling off-balance. |
| Investigate safety and efficacy of multifactorial fall reduction interventions (used successfully in older adults) in PLWH. | |||||
| Erlandson | USA | Longitudinal prospective cohort study | To identify fall risk factors among men with and without HIV | Definition, prevalence, risk factors, assessment, intervention. | Collecting real-time fall characteristics for example, circumstances, cause and injury can help identify high priority areas for interventions in falls-risk reduction by identifying falls with poor outcomes. |
| Focus on physical activity, ART adherence, and transfer to non-efavirenz ART regimens. | |||||
| Greene | USA | Cross-sectional study | To describe geriatric syndromes in older PLWH aged ≥50 with undetectable VL. | Definition, assessment, prevalence, intervention. | Comorbidities that put one at high risk of falls should be identified and treated. |
| John | USA | Cross-sectional study | To perform geriatric assessments in older PLWH in San Francisco and examine the association with age and the Veterans Ageing Cohort Study (VACS) index scores | Prevalence, assessment, intervention. | Recommended the VACS Index score for assessment of functional impairment in PLWH. |
| Specified peripheral neuropathy as a comorbidity that should be assessed and treated. | |||||
| Kim | USA | Secondary analysis of longitudinal study data | To determine whether polypharmacy is associated with falls and fractures among PLWH and substance dependence or injection drug use | Definition, prevalence, risk factors, assessment, intervention | Prescribers should avoid over prescription of non-ARV medications, especially sedating medications. |
| Richert | France | Longitudinal prospective cohort study | To assess changes in locomotor function in PLWH and to evaluate the determinants of variations in lower limb muscle performance | Prevalence, risk factors, assessment, intervention | Evaluation of efficacy of physical exercise in prevention of falls among PLWH. |
| Investigate the extent to which poor locomotor function contributes to fracture risk in PLWH | |||||
| Ruiz | USA | Longitudinal retrospective review | To investigate fall incidence and risk factors in PLWH | Definition, incidence, risk factors. | Larger studies are needed to properly characterise falls in PLWH. |
| As PLWH age more, fall risk evaluations may be needed. | |||||
| Sharma | USA | Cross-sectional study | To determine fall frequency and risk factors among middle-aged women with HIV and HIV- controls. | Definition, prevalence, risk factors, assessment, intervention. | Identify modifiable risk factors for falls including CNS-active medications and substance abuse which can be targeted as areas of fall prevention. |
| Longitudinal studies to determine if incidence and consequences for falls will be greater in women living with HIV than seronegative women. | |||||
| Sharma | USA | Longitudinal prospective cohort study | To determine the longitudinal occurrence and risk factors for falls in women with HIV and explore associations with cognition | Definition, prevalence, risk factors, assessment, intervention | Identify underlying mechanism of falls in PLWH in order to identify effective intervention strategies. |
| Ssonko | Uganda | Cross-sectional study | To determine polypharmacy prevalence, associated factors and whether polypharmacy was associated with adverse effects among older PLWH on ART | Risk factors, assessment | Considering the limitations of their study design, the association between polypharmacy and falls in PLWH may need to be explored further. |
| Tassiopoulos | USA | Longitudinal prospective multicohort study | To examine associations between frailty and fall risk among PLWH | Definition, prevalence, risk factors, assessment, intervention | Assessment and careful consideration should be given to PLWH presenting with peripheral neuropathy. |
| Womack | USA | Qualitative study | To understand perceptions of HIV+ individuals who had fallen regarding what caused their falls, prevention strategies that they used, and the impact of falls on their lives | Risk factors, intervention | Develop interventions that are specific to needs and concerns of PLWH; multidisciplinary approach should be considered. |
ART, antiretroviral therapy; ARV, antiretroviral; PLWH, people living with HIV; 5STS, 5 times sit-to-stand.
Summary of sample characteristics
| Study | Description of sample | PLWH | SNP | |||||||||||
| n | Age (years) Median (IQR) | Male (%) | Female (%) | Time since HIV diagnosis (years) Median (IQR) | On ARV (%) | PLWH with VL <LDL% (plasma HIV-1-RNA) | Current CD4+ count (cells/µL) | Nadir CD4+ count (cells/µL) | n | Age (years) Median (IQR) | Male (%) | Female (%) | ||
| Erlandson | PLWH aged 45–65 years, receiving ART from academic hospital’s infectious diseases clinic. | 359 | 52±0.3* | 85 | NR | NR | 100 | 95% (<200 c/mL) | 594±16* | NR | ||||
| Erlandson | PLWH and SNP (men and women) from the Hearing and Balance Substudy of MACS and WIHS. | 233 | 49.7 (43;55) | NR | 47 | NR | 69 | 69% (<200 c/mL) | 534† | NR | 303 | 54.9 (48;62) | NR | 18 |
| Erlandson | PLWH and SNP men aged 50 to 75 years from the Bone Strength Substudy of the MACS. | 279 | 61.1 (55.6;64.2) | 100 | 0 | NR | 100 | 91% (<50 c/mL) | NR | 36% (<200) | 379 | 62.4 (58.5;66.8) | 100 | 0 |
| 73% (>500) | ||||||||||||||
| Greene | PLWH from SCOPE cohort aged ≥50 years, on ART with VL <LDL. | 155 | 57 (54;62) | 94 | NR | 21(16;24) | 100 | NR | 567 (398;752) | 174 (51;327) | ||||
| John | Older PLWH aged ≥50 years at two San Francisco-based HIV clinics. | 359 | 57 | 85 | 12.5 | NR | 100 | 82% (<40 c/mL) | 52% (>500) | NR | ||||
| Kim | PLWH with substance dependence or injection drug use, from Boston ARCH Cohort study. | 250 | 50 (44;56) | 62 | NR | NR | 88 | 72% (<200 c/mL) | NR | NR | ||||
| Richert | Adult PLWH from the ANRS CO3 Aquitane Cohort from six public hospitals in south-western France. | 178 | 48 (43;56) | 81 | NR | 12(6;18) | 89 | 84% (<500 c/mL) | 506 (340;715) | 245 (151;371) | ||||
| Ruiz | Patient records of PLWH from an academic urban HIV clinic with history of fall in prior 12 months. | 32 | 48.19† | 25 | 75 | 9.38† | NR | 31 379 c/mL† | 342.2† | NR | ||||
| Sharma | PLWH and SNP from WIHS with available falls data. | 1 412 | 48† | 0 | 100 | NR | 87.8 | 65.4% (<20 c/mL) | 589 (385;808) | 274 (146;462) | 650 | NR | NR | NR |
| Sharma | PLWH and SNP from WIHS with available falls data and attending semi-annual study visits. | 1 816 | 48.9 (42.8;54.6) | 0 | 100 | NR | 88.3 | 63.4% (<20 c/mL) | 588 (385;781) | 280 (161;411) | 566 | 47.1 (39.9;53.8) | NR | NR |
| Ssonko | PLWH aged ≥50 years attending an outpatient HIV/AIDS care centre. | 411 | NR but aged 50 and over. | 41.8 | 58.2 | NR | 93 | NR | NR | NR | ||||
| Tassiopoulos | PLWH (men and women) aged ≥40 years from the ACTG. | 967 | 51(46;56) | 81.1 | 18.9 | NR | 100 | NR | NR | NR | ||||
| Womack | PLWH (men and women) from an HIV primary care clinic. | 21 | 55±6* | 43 | 57 | 19 (1;33) | NR | NR | NR | NR | ||||
NB. One study by Berner et al 36 is excluded from this table due to being a systematic review design.
*Mean±SD.
†Mean.
ACTG, AIDS clinical trials group; ANRS, Agence Nationale de Recherches sur le Sida et les Hépatites Virales; ARCH, Alcohol Research Collaboration on HIV/AIDS; ART, antiretroviral therapy; MACS, Multi-center AIDS Cohort Study; NR, not reported; PLWH, people living with HIV; SCOPE, Observational Study of the Consequences of the Protease Inhibitor Era; SNP, seronegative participants; VL
Summary of fall prevalence reported in included studies
| Study | Method of fall history collection | PLWH | SNP | |||||||
| Time frame assessed for falls | No of participants (n) | Overall fall prevalence (%) | Prevalence for single fall (%) | Prevalence for recurrent falls (%) | No of participants (n) | Overall fall prevalence (%) | Prevalence for single fall (%) | Prevalence for recurrent falls (%) | ||
| Berner | ||||||||||
| Erlandson | Retrospective recall | 1 year | 359 |
| 12 (F=14%) | 18 (F=26%) | ||||
| Erlandson | Retrospective recall | 1 year | 303 |
| 11 | 13 | 233 |
| 9 | 9 |
| Erlandson | Prospective reporting tool (within 24 hours). | 2 years | 279 |
| 21 | 20 | 379 |
| 22 | 17 |
| Greene | Retrospective recall | 1 year | 155 |
| NR | NR | ||||
| John | Retrospective recall | 1 year | 359 |
| NR | NR | ||||
| Kim | Retrospective recall | 1 year | 250 |
| NR | NR | ||||
| Richert | Retrospective recall | 1 year | 178 |
| NR | NR | ||||
| Ruiz | Retrospective review of patient databases. | 1 year | 2000 | |||||||
| Sharma | Retrospective recall | 6 months | 1412 |
| 9.2 | 9.4 | 650 |
| 8.3 | 10 |
| Sharma | Retrospective recall | 6 months | 1816 |
| 15.5 | 25.4 | 566 |
| 18 | 24 |
| Ssonko | Retrospective recall | 12 months | 411 | |||||||
| Tassiopoulos | Retrospective recall | 6 months | 967 |
| 11 (M=80.2%; F=19.8%) | 7 (M=72.1%; F=27.9%) | ||||
| Womack | Retrospective recall | 2 years | 21 | |||||||
Assessment of falls and risk factors.
Measures for assessing falls and risk factors.
*Prevalence not reported.
†Incidence reported.
F, female; M, male; NR, not reported; PLWH, people living with HIV; SNP, seronegative participants.
Summary of assessments tests/tools for falls and related factors used in included studies
| Key area | Test/tool | Berner | Erlandson | Erlandson | Erlandson | Kim | Richert | Ruiz | Sharma | Sharma | Ssonko | Tassiopoulos | Womack |
| Subjective assessment | |||||||||||||
| Subjective history | History of falls* | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
| Fear of falling | ✓ | ||||||||||||
| Cause of falls | ✓ | ✓ | |||||||||||
| Resulting injury or fractures | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
| Review of medications and polypharmacy | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
| Review of chronic diseases and comorbidities | ✓ | ✓ | ✓ | ✓† | ✓ | ✓ | ✓ | ✓† | ✓ | ✓ | |||
| History of alcohol, smoking and illicit substance abuse | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
| Subjective cognitive complaints | ✓ | ✓ | |||||||||||
| Environmental hazard assessment (assessed subjectively) | Lighting, wet/slippery surface, uneven surface, obstacle, step/curb, pets. | ✓ | |||||||||||
| HIV-specific variables | Duration of infection | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
| ART use | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
| Objective assessment | |||||||||||||
| Vitals | Orthostatic blood pressure | ✓ | ✓ | ✓ | |||||||||
| Sensation | 120 Hz tuning fork | ✓ | |||||||||||
| Laboratory testing | Haemoglobin, CD4 T cell count, HIV-1 RNA viral load, cholesterol. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| Standardised objective tests | |||||||||||||
| Balance | Berg Balance Scale | ✓ | |||||||||||
| Tandem stand | ✓ | ✓ | ✓ | ||||||||||
| Single leg stand | ✓ | ✓ | |||||||||||
| Forward reach | ✓ | ✓ | |||||||||||
| Timed Up and Go Test | ✓ | ✓ | |||||||||||
| The Five Times Sit to Stand (5STS) | ✓ | ✓ | ‡ | ✓ | |||||||||
| Dynamic posturography | ✓ | ||||||||||||
| Gait | 4 m walk (fast or preferred) | ✓ | ✓ | ||||||||||
| 400 m walk | ✓ | ✓ | |||||||||||
| Six-minute walk distance | ✓ | ✓ | |||||||||||
| Standardised Questionnaires/Scores | |||||||||||||
| Mental health and cognitive capacity | Depression (CES-D) | ✓ | ✓ | ✓ | ✓ | ||||||||
| Cognitive impairment | ✓§ | ✓¶ | |||||||||||
| Physical function | Functional impairment (VACS Index Score) | ✓ | |||||||||||
| Balance (ABC survey) | ✓ | ||||||||||||
| Physical activity | ✓** | ✓†† | |||||||||||
| Frailty (Fried Frailty Scores) | ✓ | ✓ | ✓‡‡ | ✓ | |||||||||
| Debilitating Pain | Pain Scale | ✓ | |||||||||||
*NB. Two cross-sectional studies by Greene et al, John et al 31 33 measured falls as part of geriatric assessments. Any other risk factors measured were not linked to falls as causality could not be claimed, hence the studies were excluded from this table. Both studies had assessed history of falls through subjective report.
†CCI.
‡Modified 10STS.
§FMMSE.
¶A5001 Neuroscreen.
**SF survey.
††IPAC.
‡‡Used a 40-item questionnaire.
ABC, Activities-Specific Balance Confidence; CCI, Charlson Comorbidity Index; CES-D, Center for Epidemiological Studies-Depression; FMMSE, Folstein’s Mini Mental State Examination; IPAC, International Physical Activity Questionnaire; SF, Short Form; VACS, Veterans Aging Cohort Study.
Figure 1ORs for risk factors significantly associated with falls in PLWH. NB. These forest plots are not a meta-analysis, which was impeded by the heterogeneity of the studies.38 ABC, Activities-Specific Balance Confidence Scale; CNS, central nervous system; DM, diabetes mellitus; HTN, hypertension; PLWH, people living with HIV; PN, peripheral neuropathy; SPPB, short physical performance battery.